+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statins and risk of treated incident diabetes in a primary care population



Statins and risk of treated incident diabetes in a primary care population



British Journal of Clinical Pharmacology 75(4): 1118-1124



(i) To examine the incidence of new onset treated diabetes in patients treated with different types of statins and (ii) the relationship between the duration and dose of statins and the subsequent development of new onset treated diabetes. A retrospective cohort study was performed using the Irish Health Services Executive Primary Care Reimbursement Services national pharmacy claims database. Individuals who received any medicines were identified from January 2001 to January 2009 (n = 1 235 671). Patients newly treated with statins from 1 January 2002 to 31 December 2007 were identified (n = 239 628). Cases were identified as individuals newly treated with antidiabetic medication (n = 38 503). Adjusted hazards ratios (HR) with 95% confidence intervals (CI) were calculated to examine the association between statins (any vs. none) and time to new onset treated diabetes using Cox proportional hazard regression. The dose and duration response relationship between statins and new onset treated diabetes was examined using restricted spline functions to assess the linearity of the relationship. Statin use was associated with an increased risk of new onset treated diabetes (HR = 1.18, 95% CI 1.15, 1.22). Increased risk of new onset treated diabetes was found with rosuvastatin (HR = 1.41, 95% CI 1.31, 1.52), atorvastatin (HR = 1.23, 95% CI 1.19, 1.27) and simvastatin (HR = 1.15, 95% CI 1.05, 1.25). There were statistically significant overall dose and duration effects for all statins, excepting fluvastatin, which only demonstrated a duration effect. An increased risk of new onset treated diabetes was found in those treated with statins showing significant duration and dose effect. Further study is required to confirm this association.

(PDF emailed within 0-6 h: $19.90)

Accession: 036514928

Download citation: RISBibTeXText

PMID: 22845189

DOI: 10.1111/j.1365-2125.2012.04403.x


Related references

Risk of incident diabetes among patients treated with statins: population based study. Bmj 346: F2610-F2610, 2013

Investigating the risk of Incident diabetes mellitus among primary care patients treated with simvastatin in North-Central Trinidad. Journal of Family Medicine and Primary Care 7(6): 1555-1560, 2019

Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk. Nutrition, Metabolism, and Cardiovascular Diseases 23(11): 1101-1106, 2014

Risk of incident diabetes among patients treated with statins ezetimibe: Lessons from a lipid clinic after an 8-year follow-up. Atherosclerosis 241(1): E223-E224, 2015

Statins and risk of incident diabetes. Lancet 375(9732): 2139; Author Reply 2141-2, 2010

Statins, cholesterol depletion and risk of incident diabetes. International Journal of Cardiology 152(2): 275-276, 2012

A One-Year Follow-Up of Individuals with Diabetes at Very High Cv Risk Treated With Statins: Outcomes and Health Care Costs. Value in Health 18(7): A380, 2015

Use of Statins and the Risk of Incident Diabetes: A Retrospective Cohort Study. American Journal of Cardiovascular Drugs 16(5): 377-390, 2017

There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular risk. Evidence-Based Medicine 15(3): 84-85, 2010

Aortic pulse wave velocity predicts incident cardiovascular events in patients with type 2 diabetes treated in primary care. Journal of Diabetes and Its Complications 30(7): 1223-1228, 2018

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Yearbook of Cardiology 2011: 267-269, 2011

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375(9716): 735-742, 2010

Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort. Clinical Endocrinology 2018, 2018

THU0082Medication Impact on The Risk of Incident Diabetes Mellitus in Patients with Rheumatoid Arthritis: Hydroxychloroquine and Abatacept Protect while Glucocorticoids and Statins Worsen: Table 1. Annals of the Rheumatic Diseases 75(Suppl 2): 208.4-209, 2016

Combining population health and baseline risk strategy by determining an age cutoff for initiating statins in patients with diabetes: a population-based study. Diabetes Care 30(8): 2025-2029, 2007